Dapotin is indicated for the treatment of premature ejaculation (PE) in men 18 to 64 years of age, who have one or all of the following:
- Persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes.
- Marked personal distress or interpersonal difficulty as a consequence of PE.
- Poor control over ejaculation.